Magnetic resonance (MR) technologists have developed three de-facto specialties over time, which could herald new training programs to meet the community’s needs.
Magnetic resonance (MR) technologists have developed three de-facto specialties over time, which could herald new training programs to meet the community’s needs.
Advancements in the medical sciences, imaging technology, and magnetic resonance clinical applications have driven the emerging specialties, said Michael L. Grey, PhD, a radiation technologist and associate professor at Southern Illinois University in Carbondale and author of the study published in the July/August 2011 issue of Radiologic Technology, a journal of the American Society of Radiologic Technologists.
Grey examined the results of an MR practice analysis questionnaire distributed to a random sample of registered MR technologists by the American Registry of Radiologic Technologists. Participants were asked to describe the type and frequency of procedures they performed.
He analyzed 78 MR tasks outlined in the survey results and found four imaging task groups that were consistently used in MR practice. Out of the four areas, three MR specialty areas emerged: vascular/cardiovascular imaging, central nervous system imaging and musculoskeletal imaging.
“When I was doing the study, I noticed that there were commonalities in each factor,” said Grey. “As I dug deeper, I discovered that MR specialty areas have developed over time.”
As new MR applications are developed, education and training programs will be needed to meet the demands of the imaging community, he added.
The results point to the need for the American Registry of Radiation Technologists (ARRT) to consider developing advanced specialty certification examinations to provide opportunities to the technologists operating MR units in the new specialty areas, he said.
But training is the first priority, Grey said, adding that “formal education and training protocols should be in place before technologists take the MR Registry exam so they are prepared to effectively practice in the area.”
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.